ITA Senior Scientist Jagpreet Chhatwal, PhD serves and as the senior and corresponding author of a paper based on a study on the benefits of directly-acting generic drugs available in India in treating hepatitis C virus (HCV). The study found the use of such drugs increased lifespan while reducing lifetime health care costs.
"Our hypothesis was that treatment would be cost saving, given the low drug costs in India. However, we were pleasantly surprised to find that the full payback was achieved so soon after treatment," said Chhatwal, who also serves as Assistant Professor of Radiology at Harvard Medical School.
To read the entire article, visit http://health.economictimes.indiatimes.com/news/pharma/how-beneficial-are-generic-hepatitis-c-drugs-available-in-india/58734705
Work by ITA Senior Scientist Amy B. Knudsen, PhD was the topic of a story on the American Cancer Society website. In the article, Dr. Knudsen states “Ultimately, we hope that the results from our study will guide the development of new screening tests for colorectal cancer, highlight important areas of focus for quality-improvement efforts in colonoscopy, and inform future screening recommendations.”
To read the complete story, visit https://www.cancer.org/latest-news/computer-simulation-aims-to-solve-colonoscopys-right-side-problem.html
Massachusetts General Hospital Cancer Center is honoring ITA Senior Scientist Carrie Lubitz, MD, MPH as one of "The One Hundred" for 2017.
Created and supported by the Massachusetts General Hospital Cancer Center, the one hundred is an awareness and fundraising initiative that celebrates hope in the cancer community. Honored each year are 100 Everyday Amazing individuals and groups — caregivers, researchers, philanthropists, advocates and volunteers from around the globe —who are taking action in the fight against cancer in inspiring and often revolutionary ways. Honorees are selected through a public nomination process and this celebration this year takes place on June 15th at the Westin Boston Waterfront Hotel.
From the article:
Through her clinical and translational research efforts, Carrie Lubitz, MD, MPH, is influencing thyroid cancer care across the world.
Dr. Lubitz has placed a high priority on prediction and decision-analytic modeling. This, in turn, has helped to assess the comparative effectiveness and improve the quality of care of patients with endocrine-related disorders. Her focus on this area is exceedingly important, as it underscores the need for cancer care to be closely aligned with the specific needs of each patient.
To read more, visit https://www.theonehundred.org/honorees/carrie-c-lubitz-md-mph/